Among multiple serological, immunological, genetic, and microbiological indices evaluated in IBD, only the performance of C-reactive protein (CRP) and fecal calprotectin (FC) was good enough to use them in clinical practice. This evidence concerns the gene CRP and inflammatory bowel disease.